Nissha shareholders wore more red ink today. The stock has dropped around 22% over the past three months and the latest quarter did not offer quick relief, with Q2 delivering a net loss of ¥5,895 million and Basic EPS of a loss of ¥124.30.
The real story sits in that profit squeeze. Revenue of ¥50,243 million could not stop trailing twelve month earnings from slipping into a loss of ¥4,601 million. For anyone thinking beyond this week’s price chart, the question now is how long the balance of weak profitability and low valuation can coexist.
Concerned that Nissha’s recent loss and shrinking earnings base could be a value trap rather than a temporary setback? You can compare it against list of solid balance sheet and fundamentals stocks (23 results).
Prefer clean charts over another dense wall of figures? See Nissha’s full financial picture, including a clear view of its recent earnings trend in the company report for Nissha.
Nissha’s transformation story leans on healthcare, sensors and sustainable materials, yet the latest figures pull in a different direction. Revenue in Q2 2026 sits only slightly above Q2 2025, while net income has swung from a small profit to a sizeable loss. Trailing 12 month earnings have also moved from profit to loss. For any bullish angle built on higher margin medical or CDMO work offsetting cyclicality elsewhere, these numbers indicate that profit contributions across the portfolio are not yet supporting that narrative.
Bears who worry about a complex industrial supplier with cyclical exposure will see these results as confirmation rather than a false alarm. Nissha has reported a deeper quarterly loss and a full year swing into the red. That aligns with concerns that diversified segments and legacy activities can weigh on overall profitability. The 3 month share price decline of around 22% and weak 7, 30 and 90 day returns suggest the market is already reacting to those pressures rather than treating them as a minor bump.
After a quarterly loss and a trailing twelve month earnings decline, it is fair to ask whether Nissha’s weaker dividend cover is a one off or a signal of deeper strain on cash generation and capital discipline. Review the independent risk analysis for Nissha which shows 1 important warning signNissha’s recent swing into losses and sharp 3 month share price decline make it a prime candidate to track closely rather than react late. Register for free with Simply Wall St and add it to a Watchlist so you can watch the share price against fair value estimates and decide on an entry point with more confidence. After you take a position, keep your decisions focused by using the Portfolio Command Center to cut through market noise and surface the updates that actually matter for your holdings. Round that out by tapping into the Community to see how other investors are thinking, so you can spot potential catalysts or red flags early and stay ahead of the market.
Fresh ideas move first. Stocks with breakout potential, new momentum or quietly dropping risk can get caught quickly. Scan curated opportunities before the crowd while it matters, act now.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com